These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 18548199)
41. A subnanomolar fluorescent probe for protein kinase CK2 interaction studies. Enkvist E; Viht K; Bischoff N; Vahter J; Saaver S; Raidaru G; Issinger OG; Niefind K; Uri A Org Biomol Chem; 2012 Nov; 10(43):8645-53. PubMed ID: 23032938 [TBL] [Abstract][Full Text] [Related]
42. Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors. Hundsdörfer C; Hemmerling HJ; Götz C; Totzke F; Bednarski P; Le Borgne M; Jose J Bioorg Med Chem; 2012 Apr; 20(7):2282-9. PubMed ID: 22377675 [TBL] [Abstract][Full Text] [Related]
43. N-substituted Indole-2 and 3-carboxamide derivatives as inhibitors of human protein kinase CK2: in vitro assay and molecular modelling study. Olgen S; Gratz A; Kurt ZK; Jose J Acta Chim Slov; 2013; 60(3):628-35. PubMed ID: 24169717 [TBL] [Abstract][Full Text] [Related]
44. Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responses. Fritz G; Issinger OG; Olsen BB Int J Oncol; 2009 Nov; 35(5):1151-7. PubMed ID: 19787270 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and proapoptotic properties of new casein kinase II inhibitors. Koronkiewicz M; Zukowska M; Chilmonczyk Z; Orzeszko A; Kazimierczuk Z Acta Pol Pharm; 2010; 67(6):635-41. PubMed ID: 21229880 [TBL] [Abstract][Full Text] [Related]
47. Hemoglobin neurotoxicity is attenuated by inhibitors of the protein kinase CK2 independent of heme oxygenase activity. Chen-Roetling J; Li Z; Regan RF Curr Neurovasc Res; 2008 Aug; 5(3):193-8. PubMed ID: 18691077 [TBL] [Abstract][Full Text] [Related]
48. Peptide biosensors for the electrochemical measurement of protein kinase activity. Kerman K; Song H; Duncan JS; Litchfield DW; Kraatz HB Anal Chem; 2008 Dec; 80(24):9395-401. PubMed ID: 18989981 [TBL] [Abstract][Full Text] [Related]
49. Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening. Nakanishi I; Murata K; Nagata N; Kurono M; Kinoshita T; Yasue M; Miyazaki T; Takei Y; Nakamura S; Sakurai A; Iwamoto N; Nishiwaki K; Nakaniwa T; Sekiguchi Y; Hirasawa A; Tsujimoto G; Kitaura K Eur J Med Chem; 2015; 96():396-404. PubMed ID: 25912672 [TBL] [Abstract][Full Text] [Related]
50. Expanding the chemical diversity of CK2 inhibitors. Prudent R; Moucadel V; López-Ramos M; Aci S; Laudet B; Mouawad L; Barette C; Einhorn J; Einhorn C; Denis JN; Bisson G; Schmidt F; Roy S; Lafanechere L; Florent JC; Cochet C Mol Cell Biochem; 2008 Sep; 316(1-2):71-85. PubMed ID: 18563535 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT. Sass G; Klinger N; Sirma H; Hashemolhosseini S; Hellerbrand C; Neureiter D; Wege H; Ocker M; Tiegs G Int J Oncol; 2011 Aug; 39(2):433-42. PubMed ID: 21567083 [TBL] [Abstract][Full Text] [Related]
52. Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors. Oramas-Royo S; Haidar S; Amesty Á; Martín-Acosta P; Feresin G; Tapia A; Aichele D; Jose J; Estévez-Braun A Bioorg Chem; 2020 Jan; 95():103520. PubMed ID: 31887475 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2. Golub AG; Bdzhola VG; Briukhovetska NV; Balanda AO; Kukharenko OP; Kotey IM; Ostrynska OV; Yarmoluk SM Eur J Med Chem; 2011 Mar; 46(3):870-6. PubMed ID: 21276643 [TBL] [Abstract][Full Text] [Related]
55. Identification of chemical inhibitors of protein-kinase CK2 subunit interaction. Laudet B; Moucadel V; Prudent R; Filhol O; Wong YS; Royer D; Cochet C Mol Cell Biochem; 2008 Sep; 316(1-2):63-9. PubMed ID: 18553057 [TBL] [Abstract][Full Text] [Related]
56. The halogenation of natural flavonoids, baicalein and chrysin, enhances their affinity to human protein kinase CK2. Marzec E; Świtalska M; Winiewska-Szajewska M; Wójcik J; Wietrzyk J; Maciejewska AM; Poznański J; Mieczkowski A IUBMB Life; 2020 Jun; 72(6):1250-1261. PubMed ID: 32364671 [TBL] [Abstract][Full Text] [Related]
57. Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2α. Winiewska M; Kucińska K; Makowska M; Poznański J; Shugar D Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1708-17. PubMed ID: 25891901 [TBL] [Abstract][Full Text] [Related]
58. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2. Prudent R; Moucadel V; Laudet B; Barette C; Lafanechère L; Hasenknopf B; Li J; Bareyt S; Lacôte E; Thorimbert S; Malacria M; Gouzerh P; Cochet C Chem Biol; 2008 Jul; 15(7):683-92. PubMed ID: 18635005 [TBL] [Abstract][Full Text] [Related]
59. Design, synthesis and evaluation of 3-quinoline carboxylic acids as new inhibitors of protein kinase CK2. Syniugin AR; Ostrynska OV; Chekanov MO; Volynets GP; Starosyla SA; Bdzhola VG; Yarmoluk SM J Enzyme Inhib Med Chem; 2016; 31(sup4):160-169. PubMed ID: 27590574 [TBL] [Abstract][Full Text] [Related]
60. Relative role of halogen bonds and hydrophobic interactions in inhibition of human protein kinase CK2α by tetrabromobenzotriazole and some C5-substituted analogues. Wasik R; Łebska M; Felczak K; Poznański J; Shugar D J Phys Chem B; 2010 Aug; 114(32):10601-11. PubMed ID: 20734498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]